Why was inter partes reexamination discontinued?

The discontinuation of inter partes reexamination was part of the broader patent reform implemented by the America Invents Act (AIA). While MPEP 2629 doesn’t provide the specific reasons, the change was made to improve the efficiency and effectiveness of patent review processes. The new inter partes review procedure conducted by the PTAB was designed to…

Read More

How does the America Invents Act (AIA) relate to derivation proceedings?

The America Invents Act (AIA) plays a crucial role in the context of derivation proceedings. According to MPEP 2310: “Derivation proceedings are only applicable to applications for patent, and any patent issuing thereon that are subject to first-inventor-to-file provisions of the America Invents Act (AIA).” This means that: Derivation proceedings are a direct result of…

Read More

How did the America Invents Act (AIA) affect ex parte reexamination?

The Leahy-Smith America Invents Act (AIA), enacted on September 16, 2012, made several significant changes to ex parte reexamination: Expanded the scope of citable information to include patent owner statements filed in federal court or USPTO proceedings. Introduced estoppel provisions related to inter partes review and post-grant review. Established a first-inventor-to-file prior art regime, replacing…

Read More

What changed for patent applications filed on or after September 16, 2012?

The MPEP 409.03(g) section on proof of irreparable damage is not applicable to patent applications filed on or after September 16, 2012. This change is due to the implementation of the America Invents Act (AIA), which brought significant reforms to the U.S. patent system. Key changes include: Transition from a ‘first-to-invent’ to a ‘first-inventor-to-file’ system…

Read More